Tower Research Capital LLC (Trc) Landos Biopharma, Inc. Transaction History

Tower Research Capital LLC (Trc)

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.26 - $0.55 $913 - $1,931	3,512 Added 19.79%	21,256 $6,000
Q4 2022 Feb 10, 2023	BUY	$0.22 - $0.51 $1,700 - $3,941	7,728 Added 77.16%	17,744 $9,000
Q3 2022 Nov 10, 2022	BUY	$0.67 - $1.26 $238 - $448	356 Added 3.69%	10,016 $7,000
Q2 2022 Aug 15, 2022	BUY	$0.6 - $1.5 $2,211 - $5,529	3,686 Added 61.7%	9,660 $7,000
Q1 2022 May 12, 2022	BUY	$1.44 - $5.22 $2,882 - $10,450	2,002 Added 50.4%	5,974 $9,000
Q4 2021 Feb 14, 2022	BUY	$4.7 - $15.0 $15,604 - $49,800	3,320 Added 509.2%	3,972 $19,000
Q3 2021 Nov 15, 2021	SELL	$9.77 - $15.77 $7,601 - $12,269	-778 Reduced 54.41%	652 $10,000
Q2 2021 Aug 16, 2021	BUY	$9.26 - $12.53 $3,916 - $5,300	423 Added 42.01%	1,430 $16,000
Q1 2021 May 17, 2021	BUY	$9.47 - $16.26 $9,536 - $16,373	1,007 New	1,007 $10,000

Ticker LABP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,254,900
Description
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of u...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.